Globe Life (GL) Q3 2025 earnings summary

Executive summary

• Net income for Q3 was $388M ($4.73/share), up 38% year-over-year; for the nine months ended September 30, 2025, net income was $895M, up from $816M, with diluted EPS rising 21% to $10.77.

• Net operating income for Q3 was $394M ($4.81/share), up 38%; for the nine months, it reached $925M, a 10% increase.

• Book value per share was $69.52 (GAAP), up 27% year-over-year; excluding AOCI, $93.63, up 12%.

• The company serves the lower middle to middle income market, which remains underserved and offers significant growth potential.

• The company repurchased 4.2 million shares for $515M and maintained a strong liquidity position.

Financial highlights

• Total premium revenue in Q3 grew 5% year-over-year; for the nine months, total premium was $3.6B, with life premium up 3% and health premium up 8%.

• Life underwriting margin increased 24% in Q3 to $482M; for the nine months, it rose 14% to $1.16B; health underwriting margin up 25% in Q3 and 4% for the nine months.

• Administrative expenses were $90M (7.3% of premium) in Q3; for the nine months, the ratio was 7.2%, unchanged year-over-year.

• Net investment income was $286M in Q3, flat year-over-year; for the nine months, $849M, down 1%.

• Fixed maturity portfolio yield was 5.26% in Q3; 5.27% for the nine months.

Outlook and guidance

• 2025 premium revenue expected to grow ~5%; life premium up 3%-3.5%, health premium up 8%-9%.

• 2025 net operating EPS guidance: $14.40-$14.60; 2026: $14.60-$15.30.

• Underwriting margins for 2025: life 44%-46%, health 25%-27%; 2026: life 40%-43%, health 24%-27%.

• Net investment income expected flat in 2025, up ~3% in 2026.

• Share repurchases projected at $685M in 2025; $85M in dividends.